Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway.
about
Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingNeuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets.NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus.High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus LNew therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Diabetes-related molecular signatures in infrared spectra of human salivaBaicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.Evaluation of PMI-5011, an ethanolic extract of Artemisia dracunculus L., on peripheral neuropathy in streptozotocin-diabetic mice.Bone marrow-derived TNF-α causes diabetic neuropathy in mice.Enriching the diet with menhaden oil improves peripheral neuropathy in streptozotocin-induced type 1 diabetic rats.Inhibition of IκB kinase (IKK) protects against peripheral nerve dysfunction of experimental diabetes.Inactivation of TNF-α ameliorates diabetic neuropathy in mice.Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.Overexpression of human HSP27 protects sensory neurons from diabetesPathogenesis of diabetic neuropathy: bad to the bone.Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathyPotential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.Ablation of a small subpopulation of diabetes-specific bone marrow-derived cells in mice protects against diabetic neuropathy.Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.Inflammation as a Therapeutic Target for Diabetic Neuropathies.Bioactive Fraction of Annona reticulata Bark (or) Ziziphus jujuba Root Bark along with Insulin Attenuates Painful Diabetic Neuropathy through Inhibiting NF-κB Inflammatory CascadeAdvanced glycation endproducts and their pathogenic roles in neurological disorders.Expression of microRNAs: potential molecular link between obesity, diabetes and cancer.What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.Painful and painless diabetic neuropathy: one disease or two?Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis.Nrf2: a potential therapeutic target for diabetic neuropathy.Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells.Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity.Protective effects of methanolic extract of Juglans regia L. leaf on streptozotocin-induced diabetic peripheral neuropathy in rats.Role of endoplasmic reticulum stress in diabetic neuropathy.The effect of hyperglycemia on neonatal immune responses in-vitro.Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.Combination of quercetin, cinnamaldehyde and hirudin protects rat dorsal root ganglion neurons against high glucose-induced injury through Nrf-2/HO-1 activation and NF-κB inhibition.
P2860
Q28389739-D41E06EF-7226-432F-8873-FA9A81B3A570Q33614346-F78D3D2D-B70A-4837-A302-706E95C38E71Q33748565-0034DDE7-3C33-47D3-A92A-15BA5A74E549Q33781251-90517420-69F0-41A0-B4E7-53B8D0C026CAQ33874485-19685C26-63BF-4EFA-9B1C-F32B4CD8A263Q34039314-8F88DB25-3B8B-4A66-ACB4-CFCBA961DDD2Q34434392-65D9DADE-0CF5-4AE9-B915-4B5E4727A51AQ34603050-B3D11185-1109-4605-BEF1-B9761BFEEE5FQ34899309-3DC00087-2268-4192-BB4D-408B1D46F77CQ35034925-A886DDAB-75AA-4FDE-9AA2-A9A344309646Q35191507-D4A8BECC-35F1-425B-84FC-C2F7F207C65AQ35543628-1B0FD0AB-9A36-4E37-BFBB-3AE569E543FCQ35785534-49C6C3C7-E314-4603-ADA7-07536987C352Q35854702-843B2404-A26C-4315-A5BF-1D04065A7A9AQ36084076-1442F0CC-8E8C-4F16-A900-3932BC11D8B4Q36796321-39C5E6F2-0714-4392-B578-ACDD399DE1CBQ36933488-93C8C90A-ECE9-43E0-A48B-2B22FC5314ADQ37133564-1625C1CF-97FC-4FB6-948D-A02687565781Q37148729-2997EFB7-AF41-407C-A7AF-475842012034Q37168753-035C43F2-D54B-48D1-BE10-9215974B7B16Q37193699-9FC9845C-208C-454C-845D-80946860043DQ37360464-46B79F25-7232-4FB9-91D2-DBDA47210AB8Q37375109-358EAEA6-D30D-4A92-8534-3F8760489158Q37450547-0DC6518C-607D-4EA8-8E08-F9DC96F6D263Q37714889-99903566-E6FE-4BE3-A7F4-43BD6284C006Q37800424-47B329AB-7722-4F5D-BB00-D3AB72B13E39Q37902256-D6D39684-7869-423D-B8CD-823C33491D6CQ38014346-8A1282BA-2CD3-4C18-97C8-3825EB2F58D4Q38107138-4B925761-C95A-42F9-B84C-E3DC3C8A2656Q38707258-9A6D1E66-A5C5-476E-9674-3FCA4C54EBCBQ39206295-608F9368-8EF0-4AE2-B89A-AFAC19F07CF8Q39906365-72CD7587-78B3-41CD-B800-97CE8C4D1183Q41771239-890770C8-93F9-4166-BC06-CA3DB464D1F7Q42003724-97B27F1C-4822-4590-84C7-532111984C0EQ42159827-459F76CD-6A4E-4ACF-B3C6-B22C9E2BCCA6Q42161911-A777A13D-047F-4723-890A-397BBE777EF1Q43240735-2246FFB9-CE78-4A37-876E-295DDE2F913EQ44083246-FF6836D3-A6EC-40BF-A7FE-B245CEA78A7DQ46250407-01ECA8B3-3532-4795-9975-EA90EF20DC41Q46313390-263B3D11-7FA3-412C-BDE5-4AC1FC1DF3C3
P2860
Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@en
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@nl
type
label
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@en
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@nl
prefLabel
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@en
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@nl
P1433
P1476
Pro-inflammatory mechanisms in ...... uclear factor kappa B pathway.
@en
P2093
Mary A Cotter
Norman E Cameron
P356
10.2174/138945008783431718
P577
2008-01-01T00:00:00Z